semaglutide stomach paralysis attorney in louisiana kentucky bowel obstruction legal team semaglutide gi law firm in louisiana semaglutide gastrointestinal louisiana semaglutide ileus lawyer law

doi: 10.1001/jama.2019.2942 56 PratleyRAmodAHoffSTKadowakiTLingvayINauckMet al

August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity

They have not been reviewed, evaluated, or approved by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease or medical condition

For comparison perspective on competitor review pools, see Hims weight loss reviews, Ro weight loss reviews, Found weight loss reviews, Sequence weight loss reviews, Sesame Care weight loss reviews, and Calibrate weight loss reviews